INTREPID ACTS AS FINANCIAL ADVISOR TO AMBRY GENETICS


Intrepid Acts as Financial Advisor to Ambry Genetics - Deal Valued at US$1 Billion


Konica Minolta recently announced its plans to acquire U.S.-based Ambry Genetics in a deal valued at US$1 billion. Intrepid's Heatlhcare Group acted as financial advisor to Ambry Genetics.


A powerful combination that will bring the world’s most comprehensive genetic-diagnostic solutions to Japan, Europe, and throughout the world


“This acquisition is the first in a series of strategic initiatives to secure a leading position for Konica Minolta in precision medicine,” said Shoei Yamana, President and CEO of Konica Minolta. “As a part of Konica Minolta, we will have the resources, technology, and scale to advance biomedical research and enable the matching of more patients in more countries with specialized medicines that target the underlying cause of their illness,” said Charles Dunlop, President and Chairman of Ambry Genetics.


Click here to read the full press release.



Latest Intrepid Healthcare News



Ed Bagdasarian
Managing Director


Steve Davis
Managing Director



Adam Abramowitz
Managing Director


Jonathan Bluth
Head of Healthcare



 

About Intrepid Investment Bankers

Intrepid provides M&A, capital raising and strategic advisory services to entrepreneurs and middle-market companies in various industry sectors. Our heritage, rooted in our founders’ successful 35-year history, breeds a culture that embraces teamwork, tenacity and creativity to win big for our clients. We believe that every company has an entrepreneurial passion that drives it and a story that defines it. Our team delivers results through skillful positioning and relentless execution. Based in Los Angeles, Intrepid augments its international capabilities through its active participation in Oaklins, an exclusive global alliance of M&A advisory firms.


About Intrepid's Healthcare Group

Intrepid's Healthcare Group is dedicated to providing strategic advice in capital raises and mergers and acquisitions across a broad range of healthcare sectors, including behavioral health, devices, diagnostics, hospitals, IT, pharmacy, physician practice management, post-acute care, and revenue cycle management. Our team maintains extensive relationships with strategic buyers and institutional investors across these sectors.


Media Contact


Andreea Popa, Director of Marketing & Communications